Indirect Pulp Capping Using Biodentine and Theracal Light-cured in Primary Molars
NCT ID: NCT06020911
Last Updated: 2024-05-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
17 participants
INTERVENTIONAL
2023-01-30
2023-10-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Comparative Study of Different Traditional and Bioactive Indirect Pulp Capping Materials
NCT06707311
Clinical and Radiographic Outcomes of Partial Pulpotomy Procedure in Primary Molars Utilizing Different Capping Materials and Different Restorative Methods
NCT06227390
Light Cured Resin Modified Calcium Silicate Versus Light Cured Calcium Hydroxide in Indirect Pulp Treatment of Primary Molars
NCT03791255
Comparison of the Clinical Performance of High Strength Hybrid Ceramic Indirect Restorations Cemented on Endodontically Treated Teeth Using Bioactive Versus Conventional Self Adhesive Resin Cements.
NCT06787469
Comparative Study Between Biodentine and Mineral Trioxide Aggregate in Direct Pulp Capping
NCT02803528
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Theracal light cured is a light-cured resin modified calcium silicate (RMCS) used as an indirect pulp capping material. It releases more calcium ions than Mineral trioxide aggregate or dycal inducing reparative dentin and dentin bridge formation.Theracal light cured showed better sealing ability and less microleakage than Mineral trioxide aggregate and Biodentine
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Biodentine
17 primary second molars of 17 children will be capped with Biodentine.
Biodentine
17 primary second molars of 17 children will be capped with Biodentine
Theracal light cured
17 primary second molars of 17 children will be capped with Theracal light cured
Theracal light cured
17 primary second molars of 17 children will be capped with Theracal light cured
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Biodentine
17 primary second molars of 17 children will be capped with Biodentine
Theracal light cured
17 primary second molars of 17 children will be capped with Theracal light cured
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Positive vital pulp testing for both hot and cold response; is determined by ethyl chloride in cold pulp testing and heated gutta percha in hot pulp testing. Pain caused by these tests should not persist after the stimulus is removed.
3. Patient and parent cooperation.
4. Accessible isolation for the operated tooth with rubber dam.
5. primary molars with cavitated carious lesion on either occlusal or proximal surface that extend into the dentin .
6. Availability of remaining dentin thickness over the pulp.
7. Normal lamina dura and periodontal ligaments. 8 Absence of external and internal root resorption.
Exclusion Criteria
2. Pain with percussion, presence of abscess and pathological mobility.
3. Uncooperative patient.
4. Progression of caries lesion to pulp and pulp exposure.
5. Presence of periapical lesion as abscess, cyst or granuloma.
6. Unhealthy bony tissues.
4 Years
7 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tanta University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Alaa Abd Elhameed Abd Elghany
Principle investigator Alaa Abd Elhameed Abd Elghany
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tanta University
Tanta, El-garbia, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
R-PED-6-21-6
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.